| # | Drug | Count |
|---|---|---|
| 0 | CABOZANTINIB | 5 |
| 1 | ACETAMINOPHEN | 4 |
| 2 | NIVOLUMAB | 4 |
| 3 | VITAMIN E | 4 |
| 4 | ACETAMINOPHEN 500MG | 3 |
| 5 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 3 |
| 6 | ALBUTEROL SULFATE | 3 |
| 7 | CLINDAMYCIN | 3 |
| 8 | DEXAMETHASONE | 3 |
| 9 | DEXAMETHASONE 1.5 MG | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERTUGLIFLOZIN | 1 | 0.0009 |
| 1 | PROCHLORPERAZINE EDISYLATE | 1 | 0.0008 |
| 2 | NIACIN | 3 | 0.0003 |
| 3 | SELENIUM | 1 | 0.0002 |
| 4 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 3 | 0.0002 |
| 5 | ESOMEPRAZOLE MAGNESIUM DIHYDRATE | 3 | 0.0002 |
| 6 | EVEROLIMUS TABLETS | 3 | 0.0002 |
| 7 | VITAMIN E | 4 | 0.0001 |
| 8 | ACETYLCYSTEINE | 1 | 0.0001 |
| 9 | CABOZANTINIB | 5 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 1 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 2 | Nicotinic Acid [EPC] | 3 | 0.0000 |
| 3 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 4 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 4 | 0.0000 |
| 6 | Androgen Receptor Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 8 | Serotonin-3 Receptor Antagonist [EPC] | 3 | 0.0000 |
| 9 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |